Role of recombinant human glicentin in the normal human jejunum: an in vitro study
- PMID: 16201096
Role of recombinant human glicentin in the normal human jejunum: an in vitro study
Abstract
Background/aims: Glicentin (GL) is known as an inhibitory factor for alimentary tract movement and the possibility that GL may be a neuromodulator of the non-adrenergic non-cholinergic (NANC) inhibitory nerves has been reported from animal experiments. Since sufficient amounts of GL have not been available for the physiological studies, there is no report concerning the effects of GL on the enteric nervous system in the normal human small intestine. Recently synthesized recombinant human GL (rh-GL) has become available to study the physiological action of GL. To clarify the physiological significance of GL in the normal human small intestine, enteric nervous responses to GL in the normal small bowel were investigated.
Methodology: Normal jejunal muscle strips (thirty-two preparations) derived from patients who underwent jejunal resection for advanced gastric cancers (14 cases) were used. The subjects consisted of 10 men and 4 women, aged from 48 to 66 years with a mean age of 59.9 years. A mechanographic technique was used to evaluate the in vitro jejunal muscle responses to GL (recombinant human GL; rh-GL) of adrenergic and cholinergic nerves before and after treatment with various autonomic nerve blockers. All muscle strips used in this study reacted to the electrical field stimulation (EFS), which was thus suitable for stimulation of enteric nervous system.
Results: In experiment I (the responses to rh-GL after blockade of the adrenergic and cholinergic nerves) the inhibition reaction ofjejunal contraction movement was concentration-dependent; 0% at 1 x 10(-9) g/mL, 6.3% at 1 x 10(-8) g/mL, 12.5% at 1 x 10(-7) g/mL, and 43.8% at 1 x 10(-6) g/mL. The remaining muscle strips demonstrated no reaction to rh-GL. In addition, significant differences were noted between 1 x 10(-9) and 1 x 10(-6) g/mL, between 1 x 10(-8) and 1 x 10(-6) g/mL, and between 1 x 10(-7) and 1 x 10(-6) g/mL (P=0.0005, P=0.0066, P=0.0359, respectively). Rh-GL concentration-dependently inhibited a contraction reaction after blockade of the adrenergic and cholinergic nerves. In experiment II (responses to rh-GL following administration of tetrodotoxin) tetrodotoxin did not block the inhibition of contraction reaction in response to rh-GL in the human jejunum. Inhibition reaction of contraction movement was seen in the jejunal muscle strips, as in experiment I.
Conclusions: GL plays an important role in the regulating inhibition of the contraction reaction in normal human jejunum via NANC nerves, and has a direct action on the jejunal muscle receptor.
Similar articles
-
The role of interleukin-1 beta (IL-1beta) in the normal human colon in vitro.Hepatogastroenterology. 2005 Mar-Apr;52(62):464-8. Hepatogastroenterology. 2005. PMID: 15816458
-
The effects of neurotensin in the colon of patients with slow transit constipation.Hepatogastroenterology. 2007 Sep;54(78):1662-6. Hepatogastroenterology. 2007. PMID: 18019689
-
Regulation of vasoactive intestinal peptide and substance P in the human pyloric sphincter.Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1403-6. Hepatogastroenterology. 2009. PMID: 19950799
-
Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.Auton Neurosci. 2006 Jun 30;126-127:232-49. doi: 10.1016/j.autneu.2006.02.014. Epub 2006 Apr 17. Auton Neurosci. 2006. PMID: 16616700 Review.
-
Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.Int J Toxicol. 2007;26 Suppl 1:3-106. doi: 10.1080/10915810601163939. Int J Toxicol. 2007. PMID: 17365137 Review.
Cited by
-
Postprandial Dynamics of Proglucagon Cleavage Products and Their Relation to Metabolic Health.Front Endocrinol (Lausanne). 2022 Jun 29;13:892677. doi: 10.3389/fendo.2022.892677. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35872982 Free PMC article. Clinical Trial.
-
Insights on glicentin, a promising peptide of the proglucagon family.Biochem Med (Zagreb). 2017 Jun 15;27(2):308-324. doi: 10.11613/BM.2017.034. Biochem Med (Zagreb). 2017. PMID: 28736498 Free PMC article. Review.
-
Fasting Circulating Glicentin Increases After Bariatric Surgery.Obes Surg. 2017 Jun;27(6):1581-1588. doi: 10.1007/s11695-016-2493-5. Obes Surg. 2017. PMID: 27987137
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources